ol.sources{margin:12px 0 0 20px;font-size:.9rem}ol.sources li{margin:6px 0}.tablewrap{overflow-x:auto;margin:18px 0}
Home / Journal / Safety
This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.
Relationship Disclosure: Semaglutide Watchdog and its publisher, US Peptides Partners LLC, have no ownership, affiliate, referral, advertising, management, reviewer, or other material financial relationship with certain providers listed on this website. All providers are evaluated using the same documented evidence, pricing, and verification methodology, regardless of relationship status.
Written by Kim Callender, NP, FNP-BC·Reviewed by Jonathan Snipes, MD·Published July 15, 2026·Category Safety

Verify the pharmacy before you verify the price

Compounded semaglutide is only as safe as the pharmacy that makes it. The pharmacy is checkable in about ten minutes, and a program that won't name it has answered your question.

The short version

Before enrolling in a compounded semaglutide program, confirm five things: the dispensing pharmacy's legal name (disclosed before you pay), its current state license (verify on the state board of pharmacy lookup), whether it is a 503A pharmacy or 503B outsourcing facility, its FDA registration if 503B (on the FDA's registered facility list), and that a prescription is required after a genuine clinician evaluation. A program that won't name its pharmacy is disqualifying.

Key takeaways

Step one: get the pharmacy's legal name

The first and most revealing test: does the program tell you which pharmacy will fill your prescription, before you pay? A legitimate operation names its pharmacy or pharmacies. “Our network of licensed pharmacies” with no names is a red flag — you cannot verify what you cannot identify, and the vagueness is usually deliberate.

Some programs disclose several possible pharmacies because fulfillment varies by state and availability; that's acceptable if each is named and verifiable. What's not acceptable is an unnamed “partner pharmacy” you only learn about, if ever, when the package arrives. The name is the key that unlocks every other check below.

Compounding pharmacy verification checklist
CheckHowPass condition
Pharmacy namedAsk before payingLegal name(s) disclosed
State licenseState board lookupCurrent, good standing
503A vs 503BAsk / pharmacy siteKnown and appropriate
FDA registration (503B)FDA outsourcing facility listListed
PrescriptionProgram intakeRequired after real evaluation
PaymentCheckoutCard processing, receipts
Verification steps that gray-market sellers typically fail
Named pharmacy95% legit passVerifiable license90% legit passPrescription required85% legit passCard payment80% legit pass

Step two: verify the state license

Every U.S. pharmacy is licensed by a state board of pharmacy, and every state board runs a free online license lookup. Enter the pharmacy's name and confirm the license is current and in good standing, licensed in a state, and — ideally — authorized to ship to yours. This takes minutes and catches the most basic failures.

A pharmacy that can't be found on any state board lookup is not a pharmacy you should let compound an injectable medication for you. Note the distinction that trips people up: state licensing is not FDA approval, and no pharmacy is “FDA-approved.” State boards license pharmacies; the FDA approves drugs and registers 503B facilities. A program claiming an “FDA-approved pharmacy” is either confused or misleading.

Step three: 503A or 503B?

Compounded semaglutide comes from one of two facility types, and the difference matters. A 503A pharmacy is a traditional compounding pharmacy that prepares patient-specific prescriptions; it is state-licensed but not subject to FDA current-good-manufacturing-practice (cGMP) requirements. A 503B outsourcing facility registers with the FDA, is inspected on a risk-based schedule, and must follow cGMP — more manufacturing assurance, more oversight.

Neither is “better” in every case, but you should know which you're getting. Post-shortage, 503A patient-specific compounding is the narrow legal lane for individualized semaglutide, while 503B copies of approved semaglutide are foreclosed. Our 503A-vs-503B guide covers what each status means for legality and quality.

Step four: check FDA registration for 503B

If the pharmacy is a 503B outsourcing facility, it must be registered with the FDA, and the FDA publishes the list of registered outsourcing facilities. Confirm the facility appears on it. Registration is not approval of any product — the FDA registers the facility, it does not approve compounded drugs — but an unregistered facility claiming 503B status is a serious warning sign.

For 503A pharmacies, there is no equivalent federal registry; the state license is your verification. In both cases, be alert to the language trap: “FDA-registered” (true for 503B facilities) is not “FDA-approved” (never true for compounded drugs). Marketing that blurs the two is testing whether you know the difference.

Step five: confirm a real prescription pathway

A legitimate program requires a prescription written after a licensed clinician actually evaluates you — a medical intake at minimum, sometimes a video visit depending on your state. If a seller offers semaglutide with no prescription, or a rubber-stamp “consultation” that approves everyone, that is the gray market, and the pharmacy questions above are usually moot because there isn't a real pharmacy behind it.

The prescription requirement is also your legal protection: possessing prescribed compounded medication is not the exposure that enforcement targets. “Research use only” products sold without prescriptions are a different and riskier category entirely — covered, with salt forms, in our gray-market guides.

The ten-minute checklist

Put together, the verification is fast: get the pharmacy's legal name before paying; find it on the state board of pharmacy license lookup and confirm current good standing; determine 503A or 503B; for 503B, confirm it's on the FDA registered-facility list; and confirm a prescription is required after a real clinician evaluation. Add the payment check — normal card processing, not crypto or gift cards — and you've screened out the large majority of unsafe sellers.

None of this requires expertise, just the willingness to spend ten minutes before spending your money and injecting the result. A program built for patients will pass every step and often volunteer the information; one built to move product will resist at the first step, which is the answer you needed.

Frequently asked questions

Is there such a thing as an 'FDA-approved pharmacy'?

No. State boards of pharmacy license pharmacies; the FDA approves drugs and registers 503B outsourcing facilities. No pharmacy is 'FDA-approved,' and a program using that phrase is either mistaken or misleading.

How do I check a pharmacy's license?

Use the relevant state board of pharmacy's online license lookup — every state has one, and they're free. Enter the pharmacy's legal name and confirm the license is current and in good standing.

What's the difference between 503A and 503B for me?

503A pharmacies prepare patient-specific prescriptions under state licensing; 503B outsourcing facilities register with the FDA and follow cGMP with FDA inspections. 503B carries more manufacturing oversight; 503A is the lane for individualized compounding.

Sources

  1. FDA — registered outsourcing facilities (503B) list
  2. NABP — pharmacy verification resources
  3. FDA — human drug compounding (503A/503B)
  4. Our 503A vs 503B guide